Evidence mapPaperPMID 33388118Full record

ArticleAtencion primaria2020

[Cardiovascular preventive recommendations. PAPPS 2020 update].

Domingo Orozco-Beltrán, Carlos Brotons Cuixart, José Juan Alemán Sánchez, José Ramón Banegas Banegas, Ana M Cebrián-Cuenca, Vicente F Gil Guillen, Enrique Martín Rioboó, Jorge Navarro Pérez

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Atencion primaria, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05893199 (Telemedicine in Atrial Fibrillation), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05893199 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care

TypeinterventionalSponsorUniversidad Miguel Hernandez de ElcheRan2023 to 2025Enrolled180ConditionsAtrial FibrillationArmsClinical monitoring using the Ti.Care app (https://ti.care/es), Usual care
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Gender Differences in the Diagnosis of Dyslipidemia: ESCARVAL-GENERO.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Domingo Orozco-BeltránUnidad de Investigación CS Cabo Huertas, Departamento San Juan de Alicante, Departamento de Medicina Clínica. Universidad Miguel Hernández, España. Electronic address: dorozcobeltran@gmail.com.
Carlos Brotons CuixartEquipo de Atención Primaria Sardenya, Barcelona, España.
José Juan Alemán SánchezDirección General de Salud Pública, Servicio Canario de la Salud, España.
José Ramón Banegas BanegasFacultad de Medicina, Universidad Autónoma de Madrid, Madrid, España.
Ana M Cebrián-CuencaCentro de Salud Cartagena Casco Antiguo, Cartagena, Murcia, España.
Vicente F Gil GuillenDepartamento de Medicina Clínica, Universidad Miguel Hernández, España.
Enrique Martín RioboóInstituto Maimónides de Investigación Biomédica de Córdoba IMIBIC Hospital Reina Sofía. Unidad de gestión clínica Poniente. Distrito sanitario Córdoba Guadalquivir, Córdoba, España.
Jorge Navarro PérezHospital Clínico Universitario, Departamento de Medicina, Universidad de Valencia, Instituto de Investigación INCLIVA, Valencia, España.
Universitat de Miguel Hernández d'Elx · ESConsorci d’Atenció Primària de Salut Barcelona Esquerra · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESServicio Canario de la Salud · ESServicio Murciano de Salud · ESUniversidad Autónoma de Madrid · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: Epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; Cardiovascular (CV) risk tables and recommendations for the calculation of CV risk; Main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; Indications for antiplatelet therapy, and recommendations for screening of atrial fibrillation. The quality of testing and the strength of the recommendation are included in the main recommendations.

Indexed as

Cardiovascular DiseasesDiabetes MellitusHypertensionHealth PromotionHumansLife StyleRisk FactorsAtencion primariaCardiovascular diseasesDiabetes mellitusEnfermedades cardiovascularesFamily medicineMedicina de familiaPreventive activitiesPrimary care

Identifiers

PMID33388118
PMCPMC7801219
OpenAlexW3117421459

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.